Estimated Revenue: $500M to $1B
Last Funding Date: 2023-01-04
Investor Type: Accelerator
Investors Number: 19
Industry: Biotechnology, Genetics, Health Care, Medical
Number Of Exists: 6
Funding Status: IPO
Technology: Neurological Disorders
Employee Number: 5001-10000
Headquarters: San Diego, California, United States
Last Funding Type: Post-IPO Debt
Total Funding: 778000000.0
Investment Stage: Early Stage Venture, Late Stage Venture
Founded Date: 1998-01-01
Acquisitions Number: Made Acquisitions